Fig. 1: Safety parameters, subjective high and drug concentrations in every treatment condition. | Neuropsychopharmacology

Fig. 1: Safety parameters, subjective high and drug concentrations in every treatment condition.

From: Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study

Fig. 1

Mean (SE) ratings of subjective high and mean (SD) 3-MMC serum concentration as a function of time after dosing are shown in the upper row. The lower rows show mean (SE) vital signs (heart rate, systolic and diastolic blood pressure, temperature) throughout each treatment condition (B=baseline); A * denotes a significant (p < 0.05) contrast between 3-MMC and placebo across all time points, with the color of the * representing the 3-MMC dose level.

Back to article page